Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
10.63
-1.88 (-15.03%)
Sep 17, 2025, 4:00 PM EDT - Market closed
Neuphoria Therapeutics Employees
As of June 30, 2024, Neuphoria Therapeutics had 24 total employees, including 8 full-time and 16 part-time employees.
Employees
24
Change
n/a
Growth
n/a
Revenue / Employee
$652,613
Profits / Employee
$242,792
Market Cap
19.98M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 24 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NEUP News
- 13 days ago - Neuphoria Therapeutics Completes Target Enrollment in Phase 3 AFFIRM-1 Trial of BNC-210 in Social Anxiety Disorder (SAD) - GlobeNewsWire
- 20 days ago - Neuphoria Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 4 months ago - Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting - GlobeNewsWire
- 4 months ago - Neuphoria Provides First Quarter 2025 Business Updates - GlobeNewsWire
- 5 months ago - Neuphoria Provides a Review of 2024 and Highlights 2025 Plans - GlobeNewsWire
- 7 months ago - Neuphoria Therapeutics to Ring the Nasdaq Opening Bell on March 3rd, 2025 - GlobeNewsWire
- 7 months ago - Neuphoria Therapeutics Inc. to Receive $15M Milestone Payment from Merck - GlobeNewsWire
- 9 months ago - Neuphoria Completes Re-domiciliation and Successor Listing on Nasdaq - GlobeNewsWire